Objective. Infants are at greatest risk for mortality from pertussis infection . Since 2005, the Advisory Committee on Immunization Practices has recommended a cocooning strategy of vaccinating all close contacts of infants with tetanus, diptheria, and acellular pertussis (Tdap) vaccine to reduce the risk of transmitting pertussis . Difficulties in establishing a complete cocoon have been reported in the literature . We determined whether families of newborns could be fully immunized against pertussis, thereby providing a complete cocoon of protection .
Pertussis, or whooping cough, remains a serious health concern in the 21st century. Among vaccine-preventable diseases in the United States, pertussis causes the greatest number of infections. 1 Intermittent pertussis epidemics continue to occur, most recently in California (2010) 2 and Washington State (2012). 3 Young children are disproportionately affected by infection with pertussis. [4] [5] [6] Among all age groups, infants younger than three months of age account for the vast majority of hospitalizations, serious complications, and deaths. 7, 8 Protecting this youngest cohort from pertussis remains problematic. An infant's immune system cannot mount an adequate immune response to currently available vaccine preparations prior to 6-8 weeks of age. 9 Full antibody protection is generally not acquired until an infant has received three diphtheria, tetanus, and pertussis vaccines at 6 months of age. 10 Thus, the most vulnerable time for disease coincides with the period when an infant is not and cannot be fully immunized.
Protecting infants from pertussis by vaccinating family members is a strategy first promoted by the Centers for Disease Control and Prevention in 2005. 11 Known as "cocooning," the concept rests on the fact that family members and other close contacts are the source of infant infections in 76%-83% of cases. 12, 13 Despite the theoretical simplicity, cocooning has proven difficult to implement. [14] [15] [16] [17] Immunizing mothers alone has been shown to be inadequate in preventing infant pertussis infection. 18 Even with resource-intensive programs, however, cocooning efforts have achieved a full cocoon in fewer than 30% of families. 19 We sought to determine whether an outpatient vaccine clinic in the inpatient setting could reach enough family members to create a complete cocoon of protection within households of newborns. Prior to our implementation of a Family Cocooning Clinic, there was no standard protocol within our institution for immunizing family members of newborns.
MetHoDS

Overview
During August-October 2010, the University of California, San Diego (UCSD), Health System sought to cocoon newborns against pertussis by offering tetanus, diptheria, and acellular pertussis (Tdap) vaccine to all household contacts. The vaccine was provided in the Family Tdap Clinic, located within the hospital in a small waiting room on the postpartum floor. The Clinic was open six days per week, from 5:00-6:30 p.m. Tdap vaccines were supplied by the California Department of Public Health and administered at no cost to patients. Staff members of the UCSD Health System approached antepartum and postpartum mothers and household contacts with educational materials about pertussis, the Tdap vaccine, and the Family Vaccine Clinic. Written information was also posted throughout the postpartum floor, as well as in numerous public spaces within the hospital (e.g., near the cafeteria, in elevators, and in waiting rooms).
Household contacts of neonates born or about to be born at UCSD Health System facilities were eligible to receive the vaccine. Contacts were self-identified and included any family members or close contacts aged 7 years and older presenting themselves to the Family Tdap Clinic. A three-question medical history was obtained from each contact, with the purpose of identifying those with contraindications (including those who reported encephalopathy or seizure after a prior vaccination, a severe latex allergy, or recent Tdap vaccination). Pharmacists and student pharmacists were the primary immunizers in a collaborative practice protocol with physicians.
This study was a case-control evaluation of the proportion of Tdap vaccine rates during the intervention period (August-October 2010) and the control period (May-July 2010). Telephone surveys were administered to 100 participants in the intervention group and 102 participants in the control group.
Selection of participants
Participant names were randomly selected from the labor and delivery logs of UCSD Health System. The case population consisted of women or family members of women who delivered babies during the Family Tdap Clinic period (August-October 2010), and the control population consisted of women or family members of women who delivered babies during the three months prior to clinic implementation (May-July 2010). One hundred subjects from the intervention group and 102 subjects from the control group were surveyed. The estimated sample size of 100 subjects for each group would detect 10% difference with alpha 5 5% and power 5 80%. Inclusion criteria were valid telephone number and willingness to participate in the study.
Participant survey
Surveys were administered via telephone interview. Investigators contacted households during January-March 2012. Participants answered questions regarding basic demographic information, number of people in the home during the weeks immediately following delivery, and number of people who received a Tdap vaccine. The definitions of tetanus-diphtheria and Tdap vaccines were provided to the households during the survey. Participants in both the case and control arms of the study were queried about vaccination status of household members at the time their newborn was discharged from the hospital. Although interviewers knew which participants were in the case or control group, a standardized script was used during the interview to minimize differences in data collection.
Analysis
Comparative analyses were performed for demographic variables (age, race, ethnicity, and education) and for rates of Tdap immunization. Analysis was performed using SPSS ® version 20.0. 20
reSultS
During the three-month intervention period, 243 postpartum patients and 1,287 family members and household contacts received Tdap vaccine, the latter in the Family Tdap Clinic. Follow-up phone interviews were conducted with 100 families who were randomly selected from the hospital's delivery log from August to October 2010 (the intervention group). Responses were compared with information obtained similarly from 102 families who delivered in the three months prior to establishment of the Family Tdap Clinic (the control group). Household contacts were defined as any family member, close friend, caregiver, or other person who was around the newborn at least one day per week.
Overall, respondents in the intervention and control groups were similar in age, sex, education, and size of household ( Table 1 ). The total numbers of household members in the intervention and control groups were 381 and 347, respectively. As a whole, the intervention group reported that 84.8% (323/381) of all household contacts of newborns were immunized prior to the newborn's discharge from the hospital, while the control group reported a 52.2% (181/347) vaccination rate among household members (p,0.05) ( Figure 1 ).
A full cocoon (i.e., all members of the household were immunized with Tdap vaccine prior to the newborn's discharge from the hospital) was reported in 76.0% of households in the intervention group and only 29.3% of households in the control group (Figure 2 ). There were no racial differences within the groups that reported full Tdap vaccine coverage. Of those surveyed in the intervention group, a complete or full cocoon was reported in 76.8% of families selfidentified as white and 75.0% of families self-identified as nonwhite (e.g., Asian/Pacific Islander, African or African American, mixed, or other). Likewise, there was no association between ethnic background and households reporting full immunization coverage. Within the intervention group, 76.9% of Hispanic households and 75.3% of non-Hispanic households reported full Tdap vaccine coverage. Education also appeared to play no role; full immunity was reported in 68.8% of respondents with a high school education, 78.6% of college-educated households, and 76.2% of those with graduate degrees in the intervention group. Within the control group, there was also no statistically significant association between age, gender, race/ ethnicity, or education and the achievement of a full household cocoon ( Table 2) .
A marginal association was noted in the intervention group between the size of the household and whether all family members had been immunized. A full cocoon there was a significant association between household size and the attainment of a full cocoon. In the control group, 46.8% of households with #2 members were fully immunized with Tdap, whereas only 13.2% of households with $4 members were fully immunized (p50.008) ( Table 3) . A partial cocoon, where some but not all members of the household had received the Tdap vaccine, was found in 24.0% of the intervention group and 53.5% of the control group. No households in the intervention group and 17.2% of households in the control group had no Tdap immunization ( Figure 2 ).
DiScuSSion
While theoretically attractive as a means of protecting infants from pertussis, the cocooning strategy has been reportedly difficult to implement. [14] [15] [16] 19 This study is the first to document a model whereby the vast majority of family members of newborns can be successfully immunized prior to the infant's hospital discharge. More than three-quarters of infants went home fully cocooned (i.e., every member of the household had received the Tdap vaccine). Rates of immunization were notable for being unaffected by demographic variables and only minimally affected by size of household. The program's success speaks to the importance of simple and common-sense concepts. Holding the Family Tdap Clinic in close proximity to the postpartum floor (i.e., a small and little-used waiting room at the end of the hallway) made it easy for families to obtain vaccine. Our decision to hold the clinic in the late afternoon/evening allowed us to balance the needs of working families while also not requiring our vaccinating staff to work too late each evening. Saturday hours also ensured that no matter when a woman delivered, she and her family would have an opportunity to receive the Tdap vaccine.
In contrast with programs that have been resourceintensive and gone to great lengths to identify each family member and household contact, 19 we essentially threw open our doors for 90 minutes most evenings and offered the Tdap vaccine to anyone who self-identified as a close contact of a newborn. The high vaccination rates achieved within households speak to the validity of our presumption that anyone who came to the hospital to visit mother and baby would likely meet the criteria for being a close contact. Such a program need not be resource-intensive nor require extensive recordkeeping on family composition.
In our study, the factors of gender, age, race/ethnicity, and education had no statistically significant association with the attainment of a complete cocoon in either the control or intervention group. However, the size of the household did significantly impact the ability to reach a full cocoon in the control group. The larger the household, the less likely all members were to be immunized with Tdap. In contrast, the size of the household in the intervention group had no such impact. It is possible that the intervention strategy reduced or eliminated this barrier. In particular, we hypothesize that the buy-in from the nursing staff and their boots-on-the-ground educational efforts were key. Individual pharmacists and physicians also made themselves available to address questions or concerns. While families generally want to maximize their children's health, 21 the presence of a newborn appears to heighten this impulse. An indelible image remains with us of speaking to eight family members of a single newborn all clustered in a postpartum room. Through a Spanish interpreter, the investigator explained the potential sequelae of pertussis in the newborn period. The grandmother of the family stood up and, with one wave of her hand, summoned the other seven members to follow her down the hallway for vaccination. We witnessed this scenario repeatedly during the intervention period. Family members, particularly mothers and grandmothers, were the prime catalysts for full cocooning within the family. Strategies are likely to be more successful when they harness the leadership within family units, as well as the heightened caretaking impulse present in the newborn period.
While this study is heartening for its successes, barriers to the establishment of successful cocooning programs remain. 22, 23 These barriers include the need to establish systems to treat outpatients in the inpatient setting, as well as the availability of vaccine for those with minimal or no health insurance. Our program had the benefit of no-cost vaccines made available through statewide public health efforts. Other institutions may find that costs of a similar program will vary, but components to consider include vaccine, supplies, labor costs to administer the vaccines, and administrative costs to document vaccination. With registration staff, postpartum nursing staff, and inpatient pharmacy staff already on the clock, the cost to our institution was minimal. The rate-limiting step for program continuation was the depletion of state-provided vaccine. We remain hopeful that more universal insurance coverage, through the implementation of the Affordable Care Act, will allow medical institutions to meet the immunization needs of families while being reimbursed for the cost of vaccine.
Limitations
Our clinic was conducted during the 2010 California pertussis epidemic, which may have made patients more aware of the need for immunization. A limitation of our study was the length of time between the intervention and surveys, which could have induced recall bias. However, given the unique location (in a hospital) and circumstances (time of new birth in the family) in which these vaccines were administered, we believe it unlikely that recall bias would be significant. When queried during the phone interviews, mothers and fathers appeared keenly aware of who had and had not been vaccinated within the family. In addition, any impact of recall bias is unlikely to change the overall conclusion of our study: that an in-hospital Tdap cocooning program can be successfully implemented.
The timing of Tdap immunization among family members also remained an issue. A period of 1-2 weeks may lapse between vaccination and the development of protective antibodies. 24 Thus, newborns may not be fully protected for the first weeks of life despite their families being fully immunized prior to hospital discharge. Options for addressing this window of vulnerability might involve directing pregnant women and families to a Family Tdap Clinic when they come to the hospital for clinic appointments, for ultrasounds, for prenatal classes, and/or for tours of the labor and delivery unit. In fall 2012, the Advisory Committee on Immunization Practices voted to recommend immunizing all pregnant women in the third trimester, which allows for the passive transfer of pertussis antibodies to the fetus prior to delivery. This strategy is promising in theory, and its effect on rates of neonatal pertussis is an area of ongoing study. 7, 25, 26 Neonatal vaccination against pertussis, while not currently recommended, is also under investigation. 27 concluSion Cocooning is unlikely to be the only strategy needed to combat infant pertussis. It should not, however, be cast aside as a strategy too difficult to implement. Indeed, our study highlights the high vaccination rates attainable with a simple and well-designed program. Based on the success of our in-hospital Family Tdap Clinic, we assert that cocooning should continue to be viewed as a potent and important weapon in the battle against this vaccine-preventable disease.
